Work

Inhibition of MyD88 by a novel inhibitor reverses two-thirds of the infarct area in myocardial ischemia and reperfusion injury.

Year: 2020

Type: article

Abstract: . Thus, our findings highlight TJ-M2010-5 as a potential therapeutic agent for MIRI treatment.

Source: PubMed

Authors: Yan Miao, Zuochuan Ding, Zhimiao Zou, Yang Yang, Min Yang, Xiaoqian Zhang, Zeyang Li, Liang Zhou, Limin Zhang, Xue Zhang, Dunfeng Du, Fengchao Jiang, Ping Zhou

Institutions: Chinese Academy of Medical Sciences & Peking Union Medical College, Tongji Hospital, Huazhong University of Science and Technology, First Affiliated Hospital of Nanchang University, Wuhan Union Hospital, Wuhan University, Renmin Hospital of Wuhan University

Language: English

Topic: Cardiac Ischemia and Reperfusion

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W3091794463

FWCI: 1.943

Cites: 37

Cited by: 21

Related to: 10